Document is current

Article History

Received: 10 June 2021

Accepted: 5 April 2022

First Online: 30 April 2022

Declarations

:

: BKP has received unrelated grant funding from GRAIL Inc. and Hologic Inc. with monies directed to Mayo Clinic. Dr. Kay Pepin is an employee at Resoundant Inc. Dr. Jun Chen is an employee who holds patents and intellectual property at Resoundant Inc. Dr. Yuxiang Zhou holds intellectual property in interventional MRI. Dr. Northfelt has research funding with Genentech/Roche (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst) Dr. Anderson has Stock and Other Ownership Interests—FlexBioTech; SafeGen Therapeutics, Consulting or Advisory Role and research funding from Merck. Dr. Vachon does not have insurance, owns stock inexact sciences, receives research funding from grail, has intellectual property with breast density software algorithms and has received travel expenses from GRAIL Inc. Dr. Ehman owns stock, has research funding, and discloses uncompensated relationships with Resoundant. Dr. Swanson discloses Precision Oncology Insights Inc. Dr. Ehman and Mayo Clinic have financial interest and intellectual properties related to MR Elastography.

: The study was approved by our research institutional review board. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.

: Patients signed informed consent regarding publishing their data. Previously presented at ASCO 20201: